Search

everythinglearnresearchcommunity

for

Search:↓

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

New medications could improve treatment for severe alopecia areata in Australia.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

Certain miRNAs may influence cashmere fiber traits in goats by affecting hair follicle activities.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Hair and skin healing involve complex cell interactions controlled by specific molecules and pathways, and hair follicle cells can help repair skin wounds.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Metabolic signals and cell shape influence how cells develop and change.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.